At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4557 Cannabis Concept
Trading 07-21 09:55:19 EDT
216.24
+1.05
+0.49%
High216.24Low213.45Vol1.54M
Open215.21D1 Closing215.20Amplitude1.30%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O18.70MT/O Rate--Tradable Shares0.00
P/B3.015023ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
GlobeNewswire  ·  19:30
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
Harrow Price Target Maintained with a $63.00/share by BTIG
Dow Jones  ·  18:01
Harrow Price Target Maintained with a $63.00/share by BTIG
Aurora UK Alpha PLC Boosts Treasury Stock and Updates Voting Rights
TIPRANKS  ·  00:12
Aurora UK Alpha PLC Boosts Treasury Stock and Updates Voting Rights
Insig AI Pushes Back AIM Admission Date for New Share Issue
TIPRANKS  ·  00:12
Insig AI Pushes Back AIM Admission Date for New Share Issue
Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
MT Newswires Live  ·  07-20 22:38
Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Clean Power Hydrogen Wins Shareholder Backing and Raises £7.3m on AIM
TIPRANKS  ·  07-20 20:57
Clean Power Hydrogen Wins Shareholder Backing and Raises £7.3m on AIM
Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026
GlobeNewswire  ·  07-20 20:00
Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026
Volex to Shift Listing from AIM to London Stock Exchange Main Market
TIPRANKS  ·  07-20 19:32
Volex to Shift Listing from AIM to London Stock Exchange Main Market
Dr Reddy's Laboratories Ltd Expected to Post Earnings of ₹8.40 a Share - Earnings Preview
Reuters  ·  07-20 19:17
Dr Reddy's Laboratories Ltd Expected to Post Earnings of ₹8.40 a Share - Earnings Preview
Harrow Says QUELL Trial of Iheezo Posts Topline Data in Q4 2026
Reuters  ·  07-20 19:07
Harrow Says QUELL Trial of Iheezo Posts Topline Data in Q4 2026
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting
GlobeNewswire  ·  07-20 19:00
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting
Dr. Reddy's Laboratories Rises Monday, Outperforms Market
Dow Jones  ·  07-20 18:31
Dr. Reddy's Laboratories Rises Monday, Outperforms Market
Restore plc Cancels Shares After July Buyback on AIM
TIPRANKS  ·  07-20 17:52
Restore plc Cancels Shares After July Buyback on AIM
Hargreave Hale AIM VCT Sets DRIS Share Price and Dividend Timetable
TIPRANKS  ·  07-20 15:23
Hargreave Hale AIM VCT Sets DRIS Share Price and Dividend Timetable
AMS publishes scheme document for H.B. Fuller cash takeover and AIM delisting
TIPRANKS  ·  07-20 14:17
AMS publishes scheme document for H.B. Fuller cash takeover and AIM delisting
Unicorn AIM VCT Cancels Shares After Targeted Buyback
TIPRANKS  ·  07-20 14:17
Unicorn AIM VCT Cancels Shares After Targeted Buyback
Aurora UK Alpha Adjusts Voting Base After Share Buyback
TIPRANKS  ·  07-18
Aurora UK Alpha Adjusts Voting Base After Share Buyback
What Teva Pharmaceutical Industries (TEVA)'s TEV‑408 Vitiligo Data and Funding Deal Means For Shareholders
Simply Wall St.  ·  07-17
What Teva Pharmaceutical Industries (TEVA)'s TEV‑408 Vitiligo Data and Funding Deal Means For Shareholders
Aecon-led Consortium Gets Winnipeg Sewage Treatment Plant Upgrade Contract
Dow Jones  ·  07-17
Aecon-led Consortium Gets Winnipeg Sewage Treatment Plant Upgrade Contract
3 Undervalued Small Caps With Insider Action Across Global Markets
Simply Wall St.  ·  07-17
3 Undervalued Small Caps With Insider Action Across Global Markets

Introduction

Company Name.
BK4557
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--